← GrantMatch
HomeGrants

Accelerating Product Excellence in Innovation and for Clinical Adoption (APEx) (U24 Clinic

This Notice of Funding Opportunity (NOFO) solicits cooperative agreement research applications to support a multidisciplinary program titled "Accelerating Product Excellence in Innovation and for Clinical Adoption" (APEx), that will facilitate advancement of promising strategies and products for tissue engineering and

AgencyNational Institutes of Health
StatusPosted
Opportunity numberRFA-DE-27-002
Posted date05/04/2026
Application deadlineJul 10, 2026 12:00:00 AM EDT
Award ceiling4,000,000
Award floornone
Estimated total funding6,000,000
Who can applyRefer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign CollaborationsNon-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Assistance Listing (CFDA)93.867, 93.121, 93.846
DescriptionThis Notice of Funding Opportunity (NOFO) solicits cooperative agreement research applications to support a multidisciplinary program titled "Accelerating Product Excellence in Innovation and for Clinical Adoption" (APEx), that will facilitate advancement of promising strategies and products for tissue engineering and regenerative medicine (TE/RM). APEx will be composed of Resource Centers (RCs) and associated Interdisciplinary Translational Projects (ITPs) in the area of therapeutics (including adult stem cell-based treatments), sensors, and diagnostics. RCs will capitalize on their available clinical, scientific, industrial, regulatory and commercialization expertise, to deliver technical support, research capacity, administrative infrastructure and regulatory and commercialization suppo
Agency contactAPEx-NOFO@nih.gov
Official listinghttps://www.grants.gov/search-results-detail/359128

🔍 Search all grants →